In our study, VEGF secretion was significantly inhibited in non-epithelioid CRL-5946 cells following FK228 treatment, suggesting that FK228 may have anti-angiogenic effects that potentially hinder tumor growth and metastasis. The gene discussed is VEGFA; the disease is neoplasm.